Dipna Pharmachem Limited (BOM:543594)
India · Delayed Price · Currency is INR 7.71
+0.29 (3.91%)
At close: Jun 23, 2026
Dipna Pharmachem Market Cap
Dipna Pharmachem has a market cap or net worth of 191.91 million as of June 24, 2026. Its market cap has decreased by -62.74% in one year.
Market Cap
191.91M
Enterprise Value
322.87M
Revenue
1.07B
Ranking
n/a
PE Ratio
8.44
Stock Price
7.71
Market Cap Chart
Since September 8, 2022, Dipna Pharmachem's market cap has decreased from 399.80M to 191.91M, a decrease of -52.00%. That is a compound annual growth rate of -17.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 202.69M | -54.38% |
| Dec 30, 2025 | 444.29M | 28.22% |
| Dec 31, 2024 | 346.49M | 171.80% |
| Dec 29, 2023 | 127.48M | -47.79% |
| Dec 30, 2022 | 244.19M | -38.92% |
| Sep 8, 2022 | 399.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Goldline Pharmaceutical | 412.61M |
| Chandra Bhagat Pharma | 331.98M |
| Medistep Healthcare | 298.40M |
| Medico Intercontinental | 251.70M |
| Pentokey Organy (India) | 228.95M |
| Zenlabs Ethica | 224.60M |
| Centuple Global | 211.08M |
| Muller & Phipps (India) | 121.13M |